Victrex plc (LON:VCT – Get Free Report) has earned a consensus rating of “Hold” from the seven research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have given a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is GBX 662.86.
Several brokerages have recently issued reports on VCT. Canaccord Genuity Group cut Victrex to a “buy” rating and set a GBX 725 target price on the stock. in a report on Friday, May 15th. Jefferies Financial Group reduced their target price on Victrex from GBX 675 to GBX 595 and set a “hold” rating on the stock in a report on Tuesday, May 12th. JPMorgan Chase & Co. dropped their price objective on shares of Victrex from GBX 725 to GBX 625 and set a “buy” rating for the company in a research note on Wednesday, March 18th. UBS Group reissued a “sell” rating and issued a GBX 575 price objective on shares of Victrex in a research note on Monday, May 11th. Finally, Berenberg Bank dropped their price objective on shares of Victrex from GBX 695 to GBX 600 and set a “hold” rating for the company in a research note on Tuesday.
Read Our Latest Stock Report on Victrex
Victrex Stock Up 1.5%
Victrex (LON:VCT – Get Free Report) last issued its earnings results on Monday, May 11th. The company reported GBX 17.20 earnings per share (EPS) for the quarter. Victrex had a negative return on equity of 4.95% and a negative net margin of 6.70%.The firm had revenue of £147.10 million for the quarter. Research analysts predict that Victrex will post 73.1078905 EPS for the current fiscal year.
Victrex Company Profile
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Featured Articles
- Five stocks we like better than Victrex
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.
